Jones Trading Assumes Precision BioSciences at Buy, Announces Price Target of $30

Benzinga Newsdesk www.benzinga.com Neutral 69.1%

Neg 0% Neu 69.1% Pos 0%

Jones Trading analyst Catherine Novack assumes Precision BioSciences (NASDAQ:DTIL) with a Buy rating and announces Price Target of $30.